Cambridge Innovation Capital
Cambridgecic.vc
Overview
Cambridge Innovation Capital is a venture capital investment firm that backs world-leading life sciences and deep tech companies with an affiliation to the Cambridge ecosystem.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TRIMTECH Therapeutics | Jun 2026 | Seed | Co-investor |
| Trent AI | Apr 2026 | Seed | Lead |
| Immutrin | Mar 2026 | Series A | Co-investor |
| BeyondMath | Feb 2026 | Seed | Lead |
| Nuclera | Jan 2026 | Series C Extension | Co-investor |
Key People
Andrew Williamson
Managing Partner
Rowan Chapman
Non Executive Director
Ian Jauncey
Operating Partner
Paul Anson
Operating Partner
Robert Tansley
Venture Partner
Anne Horgan
Partner
Ian Lane
Partner
Michael Anstey
Partner
Rob Sprawson
Partner CFO
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?